BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9344214)

  • 1. Psoralen UVA therapy for linear and generalized morphea.
    Morison WL
    J Am Acad Dermatol; 1997 Oct; 37(4):657-9. PubMed ID: 9344214
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
    Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
    J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid decrease of phototoxicity after PUVA bath therapy with 8-methoxypsoralen.
    Neumann NJ; Ruzicka T; Lehmann P; Kerscher M
    Arch Dermatol; 1996 Nov; 132(11):1394. PubMed ID: 8915329
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
    Al-Ismail D; Edwards C; Anstey AV
    Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
    Calzavara-Pinton P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid decline in photosensitivity after 8-methoxypsoralen bathwater delivery.
    Degitz K; Plewig G; Röcken M
    Arch Dermatol; 1996 Nov; 132(11):1394-5. PubMed ID: 8915330
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of scleroderma with PUVA therapy.
    Kanekura T; Fukumaru S; Matsushita S; Terasaki K; Mizoguchi S; Kanzaki T
    J Dermatol; 1996 Jul; 23(7):455-9. PubMed ID: 8772023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photochemotherapy in systemic sclerosis and severe morphea.
    Cribier B; Faradji T; Le Coz C; Oberling F; Grosshans E
    Dermatology; 1995; 191(1):25-31. PubMed ID: 8589478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of skin photosensitivity following trimethylpsoralen bath PUVA.
    Man I; Wainwright NJ; Gibbs NK; Ferguson J
    Photodermatol Photoimmunol Photomed; 2000 Oct; 16(5):211-5. PubMed ID: 11068860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
    Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of plaque-type localized scleroderma with retinoic acid and ultraviolet A plus the photosensitizer psoralen: a case series.
    Ozdemir M; Engin B; Toy H; Mevlitoglu I
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):519-21. PubMed ID: 18363929
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of PUVA bath phototoxicity.
    Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
    Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience.
    Baum S; Pavlotsky F; Shpiro D; Trau H
    Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320
    [No Abstract]   [Full Text] [Related]  

  • 15. PUVA-induced phototoxicity: incidence and causes.
    Morison WL; Marwaha S; Beck L
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):183-5. PubMed ID: 9039165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The time course of phototoxicity of topical PUVA: 8-methoxypsoralen cream-PUVA vs. 8-methoxypsoralen gel-PUVA.
    Grundmann-Kollmann M; Leiter U; Behrens S; Gottlöber P; Mooser G; Krähn G; Kerscher M
    Br J Dermatol; 1999 May; 140(5):988-90. PubMed ID: 10354061
    [No Abstract]   [Full Text] [Related]  

  • 17. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
    Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
    J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phototesting and phototoxic side effects in bath PUVA.
    Calzavara-Pinton PG; Ortel B; Carlino AM; Honigsmann H; De Panfilis G
    J Am Acad Dermatol; 1993 Apr; 28(4):657-9. PubMed ID: 8463475
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of psoralen-UVB and psoralen-UVA photochemotherapy in the treatment of psoriasis.
    de Berker DA; Sakuntabhai A; Diffey BL; Matthews JN; Farr PM
    J Am Acad Dermatol; 1997 Apr; 36(4):577-81. PubMed ID: 9092744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.